English
简体中文
Total: £ 56.28
Published Date: 2026-03-06 | Pages: 130 | Tables: 134 | Medical Care
The global Medical Anti-Thrombotic Coating market was valued at US$ 2140 million in 2025 and is anticipated to reach US$ 4224 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Anti-Thrombotic Coating competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Medical Anti-Thrombotic Coating production reached approximately 23.26 k tons, with an average global market price of around US$92,000 per ton.
The gross profit margin of major companies in the industry is between 45%–65%.
In 2025, the global production capacity of medical anti-thrombotic coating was approximately 31.01 k tons.
Medical Anti-Thrombotic Coatings are specialized surface treatments applied to blood-contacting medical devices to reduce platelet adhesion, coagulation, and thrombus formation. These coatings typically utilize heparin-based, hydrophilic polymer, or bioactive formulations to improve hemocompatibility and device safety. They play a critical role in cardiovascular and interventional procedures by lowering the risk of clot-related complications and improving clinical outcomes.
The industrial chain of Medical Anti-Thrombotic Coatings includes upstream bioactive agents, polymers, solvents, and surface modification materials. The midstream focuses on coating formulation, surface treatment processes, curing, and quality validation. Downstream applications cover catheters, guidewires, stents, vascular grafts, extracorporeal circulation devices, and implantable medical products, supported by regulatory compliance, validation testing, and technical services.
The medical anti-thrombotic coating market is driven by the rapid growth of cardiovascular diseases, aging populations, and increasing use of minimally invasive medical devices. As interventional procedures expand, demand for improved blood compatibility and device safety continues to rise. Anti-thrombotic coatings help reduce procedural risks and improve long-term performance of implanted and disposable devices. Advances in polymer science and bioactive materials enable more durable and multifunctional coating solutions. Regulatory emphasis on patient safety further accelerates adoption. Overall, the market is expected to grow steadily as medical device innovation and clinical demand for safer blood-contacting devices continue to increase.
This report delivers a comprehensive overview of the global Medical Anti-Thrombotic Coating market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Anti-Thrombotic Coating. The Medical Anti-Thrombotic Coating market size, estimates, and forecasts are provided in terms of sales volume (Kilotons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Anti-Thrombotic Coating market comprehensively. Regional market sizes by Type, by Application, by Coating Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Anti-Thrombotic Coating manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
DSM Biomedical
Surmodics
Specialty Coating Systems (SCS)
Biocoat
Coatings2Go
Thermal Spray Technologies
Hydromer
Harland Medical Systems
AST Products
Precision Coating
Surface Solutions Group
ISurTec
Whitford
AdvanSource Biomaterials
Jiangsu Biosurf Biotech
jMedtech
Segment by Type
Thin Coating
Thick Coating
Segment by Coating Method
Dip-Coated Anti-Thrombotic Layer
Spray-Coated Anti-Thrombotic Layer
Plasma-Deposited Coating
Segment by Durability Profile
Short-Term Blood-Contact Coating
Long-Term Implantable Coating
Controlled-Degradation Coating
by Application
Catheter
Stent Delivery System
Guide Wire
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Coating Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Anti-Thrombotic Coating manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Medical Anti-Thrombotic Coating sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Medical Anti-Thrombotic Coating Market Overview
1.1 Product Definition
1.2 Medical Anti-Thrombotic Coating by Type
1.2.1 Global Medical Anti-Thrombotic Coating Market Value by Type: 2025 vs 2032
1.2.2 Thin Coating
1.2.3 Thick Coating
1.3 Medical Anti-Thrombotic Coating by Coating Method
1.3.1 Global Medical Anti-Thrombotic Coating Market Value by Coating Method: 2025 vs 2032
1.3.2 Dip-Coated Anti-Thrombotic Layer
1.3.3 Spray-Coated Anti-Thrombotic Layer
1.3.4 Plasma-Deposited Coating
1.4 Medical Anti-Thrombotic Coating by Durability Profile
1.4.1 Global Medical Anti-Thrombotic Coating Market Value by Durability Profile: 2025 vs 2032
1.4.2 Short-Term Blood-Contact Coating
1.4.3 Long-Term Implantable Coating
1.4.4 Controlled-Degradation Coating
1.5 Medical Anti-Thrombotic Coating by Application
1.5.1 Global Medical Anti-Thrombotic Coating Market Value by Application: 2025 vs 2032
1.5.2 Catheter
1.5.3 Stent Delivery System
1.5.4 Guide Wire
1.5.5 Others
1.6 Global Medical Anti-Thrombotic Coating Market Size Estimates and Forecasts
1.6.1 Global Medical Anti-Thrombotic Coating Revenue 2021–2032
1.6.2 Global Medical Anti-Thrombotic Coating Sales 2021–2032
1.6.3 Global Medical Anti-Thrombotic Coating Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Medical Anti-Thrombotic Coating Market Competition by Manufacturers
2.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Anti-Thrombotic Coating Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Anti-Thrombotic Coating Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Anti-Thrombotic Coating, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Product Types and Applications
2.7 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Date of Entry into the Industry
2.8 Global Medical Anti-Thrombotic Coating Market Competitive Situation and Trends
2.8.1 Global Medical Anti-Thrombotic Coating Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Anti-Thrombotic Coating Players Market Share by Revenue
2.8.3 Global Medical Anti-Thrombotic Coating Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Anti-Thrombotic Coating Market Scenario by Region
3.1 Global Medical Anti-Thrombotic Coating Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Anti-Thrombotic Coating Sales by Region: 2021–2032
3.2.1 Global Medical Anti-Thrombotic Coating Sales by Region: 2021–2026
3.2.2 Global Medical Anti-Thrombotic Coating Sales by Region: 2027–2032
3.3 Global Medical Anti-Thrombotic Coating Revenue by Region: 2021–2032
3.3.1 Global Medical Anti-Thrombotic Coating Revenue by Region: 2021–2026
3.3.2 Global Medical Anti-Thrombotic Coating Revenue by Region: 2027–2032
3.4 North America Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.4.1 North America Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.4.3 North America Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.5.1 Europe Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.5.3 Europe Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Anti-Thrombotic Coating Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Anti-Thrombotic Coating Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.7.1 Latin America Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.7.3 Latin America Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Anti-Thrombotic Coating Sales by Type (2021–2032)
4.1.1 Global Medical Anti-Thrombotic Coating Sales by Type (2021–2026)
4.1.2 Global Medical Anti-Thrombotic Coating Sales by Type (2027–2032)
4.1.3 Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021–2032)
4.2 Global Medical Anti-Thrombotic Coating Revenue by Type (2021–2032)
4.2.1 Global Medical Anti-Thrombotic Coating Revenue by Type (2021–2026)
4.2.2 Global Medical Anti-Thrombotic Coating Revenue by Type (2027–2032)
4.2.3 Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021–2032)
4.3 Global Medical Anti-Thrombotic Coating Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Anti-Thrombotic Coating Sales by Application (2021–2032)
5.1.1 Global Medical Anti-Thrombotic Coating Sales by Application (2021–2026)
5.1.2 Global Medical Anti-Thrombotic Coating Sales by Application (2027–2032)
5.1.3 Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2021–2032)
5.2 Global Medical Anti-Thrombotic Coating Revenue by Application (2021–2032)
5.2.1 Global Medical Anti-Thrombotic Coating Revenue by Application (2021–2026)
5.2.2 Global Medical Anti-Thrombotic Coating Revenue by Application (2027–2032)
5.2.3 Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021–2032)
5.3 Global Medical Anti-Thrombotic Coating Price by Application (2021–2032)
6 Key Companies Profiled
6.1 DSM Biomedical
6.1.1 DSM Biomedical Company Information
6.1.2 DSM Biomedical Description and Business Overview
6.1.3 DSM Biomedical Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolio
6.1.5 DSM Biomedical Recent Developments/Updates
6.2 Surmodics
6.2.1 Surmodics Company Information
6.2.2 Surmodics Description and Business Overview
6.2.3 Surmodics Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Surmodics Medical Anti-Thrombotic Coating Product Portfolio
6.2.5 Surmodics Recent Developments/Updates
6.3 Specialty Coating Systems (SCS)
6.3.1 Specialty Coating Systems (SCS) Company Information
6.3.2 Specialty Coating Systems (SCS) Description and Business Overview
6.3.3 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolio
6.3.5 Specialty Coating Systems (SCS) Recent Developments/Updates
6.4 Biocoat
6.4.1 Biocoat Company Information
6.4.2 Biocoat Description and Business Overview
6.4.3 Biocoat Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Biocoat Medical Anti-Thrombotic Coating Product Portfolio
6.4.5 Biocoat Recent Developments/Updates
6.5 Coatings2Go
6.5.1 Coatings2Go Company Information
6.5.2 Coatings2Go Description and Business Overview
6.5.3 Coatings2Go Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Coatings2Go Medical Anti-Thrombotic Coating Product Portfolio
6.5.5 Coatings2Go Recent Developments/Updates
6.6 Thermal Spray Technologies
6.6.1 Thermal Spray Technologies Company Information
6.6.2 Thermal Spray Technologies Description and Business Overview
6.6.3 Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolio
6.6.5 Thermal Spray Technologies Recent Developments/Updates
6.7 Hydromer
6.7.1 Hydromer Company Information
6.7.2 Hydromer Description and Business Overview
6.7.3 Hydromer Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hydromer Medical Anti-Thrombotic Coating Product Portfolio
6.7.5 Hydromer Recent Developments/Updates
6.8 Harland Medical Systems
6.8.1 Harland Medical Systems Company Information
6.8.2 Harland Medical Systems Description and Business Overview
6.8.3 Harland Medical Systems Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolio
6.8.5 Harland Medical Systems Recent Developments/Updates
6.9 AST Products
6.9.1 AST Products Company Information
6.9.2 AST Products Description and Business Overview
6.9.3 AST Products Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AST Products Medical Anti-Thrombotic Coating Product Portfolio
6.9.5 AST Products Recent Developments/Updates
6.10 Precision Coating
6.10.1 Precision Coating Company Information
6.10.2 Precision Coating Description and Business Overview
6.10.3 Precision Coating Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Precision Coating Medical Anti-Thrombotic Coating Product Portfolio
6.10.5 Precision Coating Recent Developments/Updates
6.11 Surface Solutions Group
6.11.1 Surface Solutions Group Company Information
6.11.2 Surface Solutions Group Description and Business Overview
6.11.3 Surface Solutions Group Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolio
6.11.5 Surface Solutions Group Recent Developments/Updates
6.12 ISurTec
6.12.1 ISurTec Company Information
6.12.2 ISurTec Description and Business Overview
6.12.3 ISurTec Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ISurTec Medical Anti-Thrombotic Coating Product Portfolio
6.12.5 ISurTec Recent Developments/Updates
6.13 Whitford
6.13.1 Whitford Company Information
6.13.2 Whitford Description and Business Overview
6.13.3 Whitford Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Whitford Medical Anti-Thrombotic Coating Product Portfolio
6.13.5 Whitford Recent Developments/Updates
6.14 AdvanSource Biomaterials
6.14.1 AdvanSource Biomaterials Company Information
6.14.2 AdvanSource Biomaterials Description and Business Overview
6.14.3 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolio
6.14.5 AdvanSource Biomaterials Recent Developments/Updates
6.15 Jiangsu Biosurf Biotech
6.15.1 Jiangsu Biosurf Biotech Company Information
6.15.2 Jiangsu Biosurf Biotech Description and Business Overview
6.15.3 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolio
6.15.5 Jiangsu Biosurf Biotech Recent Developments/Updates
6.16 jMedtech
6.16.1 jMedtech Company Information
6.16.2 jMedtech Description and Business Overview
6.16.3 jMedtech Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 jMedtech Medical Anti-Thrombotic Coating Product Portfolio
6.16.5 jMedtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Anti-Thrombotic Coating Industry Chain Analysis
7.2 Medical Anti-Thrombotic Coating Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Anti-Thrombotic Coating Production Mode & Process Analysis
7.4 Medical Anti-Thrombotic Coating Sales and Marketing
7.4.1 Medical Anti-Thrombotic Coating Sales Channels
7.4.2 Medical Anti-Thrombotic Coating Distributors
7.5 Medical Anti-Thrombotic Coating Customer Analysis
8 Medical Anti-Thrombotic Coating Market Dynamics
8.1 Medical Anti-Thrombotic Coating Industry Trends
8.2 Medical Anti-Thrombotic Coating Market Drivers
8.3 Medical Anti-Thrombotic Coating Market Challenges
8.4 Medical Anti-Thrombotic Coating Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Medical Anti-Thrombotic Coating Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Medical Anti-Thrombotic Coating Market Value by Coating Method (US$ Million), 2025 vs 2032
Table 3. Global Medical Anti-Thrombotic Coating Market Value by Durability Profile (US$ Million), 2025 vs 2032
Table 4. Global Medical Anti-Thrombotic Coating Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Medical Anti-Thrombotic Coating Market Competitive Situation by Manufacturers in 2025
Table 6. Global Medical Anti-Thrombotic Coating Sales (Kilotons) of Key Manufacturers (2021–2026)
Table 7. Global Medical Anti-Thrombotic Coating Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Medical Anti-Thrombotic Coating Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Medical Anti-Thrombotic Coating Average Price (US$/Ton) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Medical Anti-Thrombotic Coating, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Product Types and Applications
Table 14. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Medical Anti-Thrombotic Coating Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Anti-Thrombotic Coating Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Medical Anti-Thrombotic Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2021–2026
Table 20. Global Medical Anti-Thrombotic Coating Sales Market Share by Region (2021–2026)
Table 21. Global Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2027–2032
Table 22. Global Medical Anti-Thrombotic Coating Sales Market Share by Region (2027–2032)
Table 23. Global Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2021–2026
Table 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021–2026)
Table 25. Global Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2027–2032
Table 26. Global Medical Anti-Thrombotic Coating Revenue Market Share by Region (2027–2032)
Table 27. North America Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
Table 29. North America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
Table 30. North America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
Table 31. North America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
Table 34. Europe Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
Table 35. Europe Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2021–2026
Table 39. Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2027–2032
Table 40. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
Table 44. Latin America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
Table 45. Latin America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
Table 49. Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
Table 50. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
Table 52. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Type (2021–2026)
Table 53. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Type (2027–2032)
Table 54. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021–2026)
Table 55. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2027–2032)
Table 56. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021–2026)
Table 59. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2027–2032)
Table 60. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2021–2026)
Table 61. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2027–2032)
Table 62. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Application (2021–2026)
Table 63. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Application (2027–2032)
Table 64. Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2021–2026)
Table 65. Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2027–2032)
Table 66. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021–2026)
Table 69. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2027–2032)
Table 70. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2021–2026)
Table 71. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2027–2032)
Table 72. DSM Biomedical Company Information
Table 73. DSM Biomedical Description and Business Overview
Table 74. DSM Biomedical Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 75. DSM Biomedical Medical Anti-Thrombotic Coating Product
Table 76. DSM Biomedical Recent Developments/Updates
Table 77. Surmodics Company Information
Table 78. Surmodics Description and Business Overview
Table 79. Surmodics Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 80. Surmodics Medical Anti-Thrombotic Coating Product
Table 81. Surmodics Recent Developments/Updates
Table 82. Specialty Coating Systems (SCS) Company Information
Table 83. Specialty Coating Systems (SCS) Description and Business Overview
Table 84. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 85. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product
Table 86. Specialty Coating Systems (SCS) Recent Developments/Updates
Table 87. Biocoat Company Information
Table 88. Biocoat Description and Business Overview
Table 89. Biocoat Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 90. Biocoat Medical Anti-Thrombotic Coating Product
Table 91. Biocoat Recent Developments/Updates
Table 92. Coatings2Go Company Information
Table 93. Coatings2Go Description and Business Overview
Table 94. Coatings2Go Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 95. Coatings2Go Medical Anti-Thrombotic Coating Product
Table 96. Coatings2Go Recent Developments/Updates
Table 97. Thermal Spray Technologies Company Information
Table 98. Thermal Spray Technologies Description and Business Overview
Table 99. Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 100. Thermal Spray Technologies Medical Anti-Thrombotic Coating Product
Table 101. Thermal Spray Technologies Recent Developments/Updates
Table 102. Hydromer Company Information
Table 103. Hydromer Description and Business Overview
Table 104. Hydromer Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 105. Hydromer Medical Anti-Thrombotic Coating Product
Table 106. Hydromer Recent Developments/Updates
Table 107. Harland Medical Systems Company Information
Table 108. Harland Medical Systems Description and Business Overview
Table 109. Harland Medical Systems Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 110. Harland Medical Systems Medical Anti-Thrombotic Coating Product
Table 111. Harland Medical Systems Recent Developments/Updates
Table 112. AST Products Company Information
Table 113. AST Products Description and Business Overview
Table 114. AST Products Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 115. AST Products Medical Anti-Thrombotic Coating Product
Table 116. AST Products Recent Developments/Updates
Table 117. Precision Coating Company Information
Table 118. Precision Coating Description and Business Overview
Table 119. Precision Coating Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 120. Precision Coating Medical Anti-Thrombotic Coating Product
Table 121. Precision Coating Recent Developments/Updates
Table 122. Surface Solutions Group Company Information
Table 123. Surface Solutions Group Description and Business Overview
Table 124. Surface Solutions Group Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 125. Surface Solutions Group Medical Anti-Thrombotic Coating Product
Table 126. Surface Solutions Group Recent Developments/Updates
Table 127. ISurTec Company Information
Table 128. ISurTec Description and Business Overview
Table 129. ISurTec Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 130. ISurTec Medical Anti-Thrombotic Coating Product
Table 131. ISurTec Recent Developments/Updates
Table 132. Whitford Company Information
Table 133. Whitford Description and Business Overview
Table 134. Whitford Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 135. Whitford Medical Anti-Thrombotic Coating Product
Table 136. Whitford Recent Developments/Updates
Table 137. AdvanSource Biomaterials Company Information
Table 138. AdvanSource Biomaterials Description and Business Overview
Table 139. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 140. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product
Table 141. AdvanSource Biomaterials Recent Developments/Updates
Table 142. Jiangsu Biosurf Biotech Company Information
Table 143. Jiangsu Biosurf Biotech Description and Business Overview
Table 144. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 145. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product
Table 146. Jiangsu Biosurf Biotech Recent Developments/Updates
Table 147. jMedtech Company Information
Table 148. jMedtech Description and Business Overview
Table 149. jMedtech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 150. jMedtech Medical Anti-Thrombotic Coating Product
Table 151. jMedtech Recent Developments/Updates
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Medical Anti-Thrombotic Coating Distributors List
Table 155. Medical Anti-Thrombotic Coating Customers List
Table 156. Medical Anti-Thrombotic Coating Market Trends
Table 157. Medical Anti-Thrombotic Coating Market Drivers
Table 158. Medical Anti-Thrombotic Coating Market Challenges
Table 159. Medical Anti-Thrombotic Coating Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 163. Authors List of This Report
List of Figures
Figure 1. Product Picture of Medical Anti-Thrombotic Coating
Figure 2. Global Medical Anti-Thrombotic Coating Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Medical Anti-Thrombotic Coating Market Share by Type: 2025 & 2032
Figure 4. Thin Coating Product Picture
Figure 5. Thick Coating Product Picture
Figure 6. Global Medical Anti-Thrombotic Coating Market Value by Coating Method (US$ Million), 2021–2032
Figure 7. Global Medical Anti-Thrombotic Coating Market Share by Coating Method: 2025 vs 2032
Figure 8. Dip-Coated Anti-Thrombotic Layer Product Picture
Figure 9. Spray-Coated Anti-Thrombotic Layer Product Picture
Figure 10. Plasma-Deposited Coating Product Picture
Figure 11. Global Medical Anti-Thrombotic Coating Market Value by Durability Profile (US$ Million), 2021–2032
Figure 12. Global Medical Anti-Thrombotic Coating Market Share by Durability Profile: 2025 vs 2032
Figure 13. Short-Term Blood-Contact Coating Product Picture
Figure 14. Long-Term Implantable Coating Product Picture
Figure 15. Controlled-Degradation Coating Product Picture
Figure 16. Global Medical Anti-Thrombotic Coating Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Medical Anti-Thrombotic Coating Market Share by Application: 2025 & 2032
Figure 18. Catheter
Figure 19. Stent Delivery System
Figure 20. Guide Wire
Figure 21. Others
Figure 22. Global Medical Anti-Thrombotic Coating Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Medical Anti-Thrombotic Coating Market Size (US$ Million), 2021–2032
Figure 24. Global Medical Anti-Thrombotic Coating Sales (Kilotons), 2021–2032
Figure 25. Global Medical Anti-Thrombotic Coating Average Price (US$/Ton), 2021–2032
Figure 26. Medical Anti-Thrombotic Coating Report Years Considered
Figure 27. Medical Anti-Thrombotic Coating Sales Share by Manufacturers in 2025
Figure 28. Global Medical Anti-Thrombotic Coating Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Medical Anti-Thrombotic Coating Players: Market Share by Revenue in Medical Anti-Thrombotic Coating in 2025
Figure 30. Medical Anti-Thrombotic Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Medical Anti-Thrombotic Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
Figure 33. North America Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
Figure 34. United States Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
Figure 37. Europe Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
Figure 38. Germany Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Medical Anti-Thrombotic Coating Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021–2032)
Figure 45. China Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
Figure 53. Latin America Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Medical Anti-Thrombotic Coating by Type (2021–2032)
Figure 64. Global Revenue Market Share of Medical Anti-Thrombotic Coating by Type (2021–2032)
Figure 65. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2021–2032)
Figure 66. Global Sales Market Share of Medical Anti-Thrombotic Coating by Application (2021–2032)
Figure 67. Global Revenue Market Share of Medical Anti-Thrombotic Coating by Application (2021–2032)
Figure 68. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2021–2032)
Figure 69. Medical Anti-Thrombotic Coating Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
